Hughson, Richard L.

Our understanding of altered neuro‐cardiovascular control following long‐duration inactivity via head‐down bed rest (HDBR) is incomplete. Here, we retrospectively analyzed two long‐duration HDBR studies, including female (n=17; 32±5 years) and male (n=16; 29±7 years) cohorts, to determine whether HDBR 1) alters spontaneous cardiovagal baroreflex sensitivity (cBRS) similarly between males and females and 2) alters spontaneous baroreflex control of muscle sympathetic action potentials (AP) in males. Heart rate (HR; electrocardiogram) and arterial blood pressure (BP; finger‐plethysmography) were continuously measured during 5‐minutes of supine rest prior to and following 60‐days bed rest in a ‐6° head‐down position. Spontaneous cBRS was assessed by the relationship between R‐R interval and systolic BP analyzed using the linear regression sequence method. Recordings of multi‐unit muscle sympathetic nerve activity (peroneal microneurography) were obtained and a continuous wavelet transform detected APs which were grouped into AP clusters with similar morphology (n=10, all males). Baroreflex threshold for AP cluster discharge was assessed by linear regression analysis of the relationship between AP cluster discharge probability and diastolic BP. No change in resting HR (64±9 versus 66±9 /min, P=0.12) or mean BP (91.2±9.0 versus 90.6±9.2 mmHg, P=0.73) occurred after HDBR. Reductions in cBRS after HDBR (‐4.1±9.4 ms/mmHg, Time effect: P<0.01) were similar between males and females (Time‐by‐Sex effect: P=0.51) and not related to changes in total blood volume (r 2 =0.045, P=0.24). Grouped AP clusters demonstrated heterogenous arterial baroreflex threshold gain according to AP cluster morphology (Cluster effect: P<0.01) which was unaltered following HDBR (Time‐by‐Cluster effect: P=0.43). In summary, males and females similarly attenuate cBRS following 60‐days of HDBR and novel evidence indicates HDBR does not alter spontaneous baroreflex control of muscle sympathetic APs in males.

We tested the hypothesis that ACh or nitric oxide (NO) might be involved in the vasodilation that accompanies a single contraction of the forearm. Eight adults (3 women and 5 men) completed single 1-s-duration contractions of the forearm to raise and lower a weight equivalent to ∼20% maximal voluntary contraction through a distance of 5 cm. In a second protocol, each subject had a cuff, placed completely about the forearm, inflated to 120 mmHg for a 1-s period, then released as a simulation of the mechanical effect of muscle contraction. Three conditions were studied, always in this order: 1) control, with intra-arterial infusion of saline; 2) after muscarinic blockade with atropine; and 3) after NO synthase inhibition with N G-monomethyl-l-arginine (l-NMMA) plus atropine. Forearm blood flow (FBF), measured by combined pulsed and echo Doppler ultrasound, was reduced at rest with l-NMMA-atropine compared with the other two conditions. After the single contraction, there were no effects of atropine, butl-NMMA reduced the peak FBF and the total postcontraction hyperemia. After the single cuff inflation, atropine had no effects, whereasl-NMMA caused changes similar to those seen after contraction, reducing the peak FBF and the total hyperemia. The observation thatl-NMMA reduced FBF in response to both cuff inflation and a brief contraction indicates that NO from the vascular endothelium might modulate the basal level of vascular tone and the mechanical component of the hyperemia with exercise. It is unlikely that ACh and NO from the endothelium are involved in the dilator response to a single muscle contraction.

The contributions of acetylcholine and/or nitric oxide (NO) to the rapid changes in human forearm blood flow (FBF) at the onset and recovery from mild exercise were studied in eight subjects. Rhythmic handgrip contractions were performed during brachial artery infusions of saline (2 ml/min; control), atropine (0.2 mg over 3 min), to block acetylcholine binding to muscarinic receptors, or atropine + N G-monomethyl-l-arginine (l-NMMA; 4 mg/min for 4 min), to additionally inhibit NO synthase. Brachial artery mean blood velocity (MBV; pulsed Doppler ultrasound) and diameter (echo Doppler) were measured continuously, and FBF was calculated. Atropine reduced acetylcholine-induced increases in FBF by ∼71% ( P < 0.05). FBF at rest was reduced by atropine and further reduced with atropine +l-NMMA. Both drug conditions reduced FBF during exercise by ∼10% compared with control, with no difference between drug treatments. Brachial artery diameter was unchanged from rest by exercise, recovery, and drug treatments. Neither drug treatment altered the rate or magnitude of the increase in FBF above rest. Peak FBF after exercise was reduced by atropine and atropine + l-NMMA. Total FBF during 5 min of recovery was reduced with atropine +l-NMMA compared with control and atropine. The results suggest that 1) acetylcholine and NO mechanisms additively contribute to FBF levels at rest, 2) a cholinergic mechanism adjusts the absolute FBF levels during exercise, 3) neither acetylcholine nor NO is essential to observe the normal time course or magnitude of the exercise response, and 4) NO contributes to the FBF response during recovery from exercise.